Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ Cooperative Group.
González-Barón M, Feliu J, Espinosa E, García-Girón C, Chacón I, Garrido P, Colmenarejo A, Ordóñez A, Zamora P. González-Barón M, et al. Among authors: garcia giron c. Cancer Chemother Pharmacol. 1995;36(3):255-8. doi: 10.1007/BF00685856. Cancer Chemother Pharmacol. 1995. PMID: 7781148 Clinical Trial.
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
González Barón M, Feliu J, Espinosa E, García Girón C, Blanco E, Garrido P, Colmenarejo A, Ordóñez A, Moyano A, de la Gándara I, et al. González Barón M, et al. Among authors: garcia giron c. Ann Oncol. 1994 Apr;5(4):323-7. doi: 10.1093/oxfordjournals.annonc.a058834. Ann Oncol. 1994. PMID: 8075028 Free article. Clinical Trial.
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
González Barón M, Artal A, Garrido P, García Girón C, Ordóñez A, Feliu J, Berrocal A, Barón JM. González Barón M, et al. Among authors: garcia giron c. Am J Clin Oncol. 1993 Aug;16(4):310-4. doi: 10.1097/00000421-199308000-00006. Am J Clin Oncol. 1993. PMID: 8392287 Clinical Trial.
Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen.
Feliu J, González Barón M, Chacón JI, Espinosa E, Garrido P, Castro J, Escobar Y, Colmenarejo A, Jara C, García Girón C, Espinosa J, Ordóñez A. Feliu J, et al. Among authors: garcia giron c. Cancer Chemother Pharmacol. 1996;38(2):191-4. doi: 10.1007/s002800050469. Cancer Chemother Pharmacol. 1996. PMID: 8616911 Clinical Trial.
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P. Feliu J, et al. Among authors: garcia alfonso p, garcia giron c. Cancer. 1996 Jul 15;78(2):211-6. doi: 10.1002/(SICI)1097-0142(19960715)78:2<211::AID-CNCR4>3.0.CO;2-O. Cancer. 1996. PMID: 8673994 Clinical Trial.
Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain.
Feliu J, González Barón M, García Girón C, Espinosa E, Vicent JM, Gómez Navarro J, Berrocal A, Ordóñez A, Vilches Y, de Castro J, Díaz J. Feliu J, et al. Among authors: garcia giron c. Am J Clin Oncol. 1996 Dec;19(6):577-80. doi: 10.1097/00000421-199612000-00009. Am J Clin Oncol. 1996. PMID: 8931675 Clinical Trial.
103 results